---
figid: PMC7696687__cells-09-02444-g001
figtitle: Three-mammalian nicotinamide adenine dinucleotide (NAD+) biosynthesis pathways
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Sus scrofa
- Phytolacca americana
pmcid: PMC7696687
filename: cells-09-02444-g001.jpg
figlink: pmc/articles/PMC7696687/figure/cells-09-02444-f001/
number: F1
caption: 'The three-mammalian nicotinamide adenine dinucleotide (NAD+) biosynthesis
  pathways. De novo synthesis and the Preiss–Handler pathway start from nutritionally-derived
  tryptophan (essential amino acid) and nicotinic acid (NA), respectively. Both will
  eventually yield nicotinic acid mononucleotide (NAMN), which will be converted to
  nicotinic acid adenine dinucleotide (NAAD) via nicotinamide mononucleotide adenylyltransferases
  (NMNATs). NAAD conversion to NAD+ is catalyzed by nicotinamide adenine dinucleotide
  synthetase (NADS). Nicotinamide (NAM) constitute an important precursor for NAD+
  inside the cell via the salvage (rescue) pathway. NAM is the product of several
  NAD+ dependent enzymes: sirtuins (SIRTs), poly (ADP-ribose) polymerases (PARPs),
  mono (ADP-ribose) transferases (MARTs), cluster of differentiation 38 (CD38) and
  CD157. NAM will be converted to nicotinamide mononucleotide (NMN) in the rate determining
  step of the salvage pathway via nicotinamide phosphoribosyltransferase (NAMPT) or
  visfatin. NAD+ may be regenerated from NMN via nicotinamide mononucleotide adenylyltransferase
  (NMNAT).'
papertitle: 'Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders.'
reftext: Ali Dakroub, et al. Cells. 2020 Nov;9(11):2444.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.909432
figid_alias: PMC7696687__F1
figtype: Figure
organisms_ner:
- Sus scrofa
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC7696687__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7696687__cells-09-02444-g001.html
  '@type': Dataset
  description: 'The three-mammalian nicotinamide adenine dinucleotide (NAD+) biosynthesis
    pathways. De novo synthesis and the Preiss–Handler pathway start from nutritionally-derived
    tryptophan (essential amino acid) and nicotinic acid (NA), respectively. Both
    will eventually yield nicotinic acid mononucleotide (NAMN), which will be converted
    to nicotinic acid adenine dinucleotide (NAAD) via nicotinamide mononucleotide
    adenylyltransferases (NMNATs). NAAD conversion to NAD+ is catalyzed by nicotinamide
    adenine dinucleotide synthetase (NADS). Nicotinamide (NAM) constitute an important
    precursor for NAD+ inside the cell via the salvage (rescue) pathway. NAM is the
    product of several NAD+ dependent enzymes: sirtuins (SIRTs), poly (ADP-ribose)
    polymerases (PARPs), mono (ADP-ribose) transferases (MARTs), cluster of differentiation
    38 (CD38) and CD157. NAM will be converted to nicotinamide mononucleotide (NMN)
    in the rate determining step of the salvage pathway via nicotinamide phosphoribosyltransferase
    (NAMPT) or visfatin. NAD+ may be regenerated from NMN via nicotinamide mononucleotide
    adenylyltransferase (NMNAT).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD38
  - NMNAT2
  - NMNAT1
  - NMNAT3
  - ACID
  - NAMPT
  - BST1
  - STAC3
  - Cd38
  - Bst1
  - Nmnat2
  - Nmnat1
  - Nmnat3
  - Nampt
  - Tryptophan
  - NADS
  - NAAD
  - NAD
  - Nicotinic Acid
  - Visfatin
  - NAMPT
---
